# Prevention of Atrial Fibrillation by Inhibition Conversion Enzyme (ICE) After Radiofrequency Ablation of Atrial Flutter

> **NCT00736294** · PHASE3 · TERMINATED · sponsor: **Centre Hospitalier Universitaire de Saint Etienne** · enrollment: 198 (actual)

## Conditions studied

- Atrial Fibrillation
- Atrial Flutter

## Interventions

- **DRUG:** Ramipril
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00736294
- **Lead sponsor:** Centre Hospitalier Universitaire de Saint Etienne
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-07
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 198 (ACTUAL)
- **Why stopped:** Difficulty to include patients
- **Last updated:** 2015-07-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00736294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00736294, "Prevention of Atrial Fibrillation by Inhibition Conversion Enzyme (ICE) After Radiofrequency Ablation of Atrial Flutter". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00736294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*